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In this IssueWe live in a microbial world and are often confronted with infection and injury. Inflammation, the response that is
unleashed to ward off these insults, has long been familiar to us. Indeed, the words that we still use to describe inflam-
mation—redness and swelling with heat and pain—were coined in the first century A.D. by the Roman physician Aulus
Cornelius Celsus: rubor et tumor cum calore et dolore. The word inflammation itself comes from the Latin inflammare:
to set on fire. Research has taken us a long way from this first description of the overt symptoms of inflammation
2000 years ago to our current understanding of the molecular and cellular pathways that mediate the inflammatory
process, regulate it, and lead to its resolution. We now know that inflammation can come in many forms and modalities
depending on the context in which it is triggered, the trigger itself, and the tissues involved. Furthermore, we appreciate
the contribution of inflammation to cancer and to chronic afflictions like neurodegenerative diseases and diabetes.
In this year’s Special Review Issue, we bring together Review articles and Essays that survey our current knowledge of
inflammation and provide perspectives on the key questions and challenges ahead. We would like to thank the distin-
guished experts who contributed their time and effort as authors and reviewers tomake this issue timely, comprehensive,
and thought provoking. We hope that this collection of articles will be informative and inspiring, as we now harness the
tools of modern biology in the continued effort to understand ‘‘the old flame.’’Inflammation, Our Constant Companion
In an Overview Essay (page 771), Ruslan Medzhitov takes us on a tour of historical milestones in inflam-
mation research and discusses how our understanding of both the inflammatory process and its role in
homeostasis and disease has progressed. The Essay presents inflammation as an adaptive response
aimed at restoring homeostasis and highlights the importance of incorporating this concept in the study
of the chronic inflammation that accompanies diseases of homeostasis like diabetes and obesity.
The importance of inflammation in tissue homeostasis is further explored by Laurence Zitvogel, Oliver
Kepp, and Guido Kroemer (Essay, page 798), who examine the complex interplay between cell death
and inflammation. The authors discuss the molecular signals by which dying cells communicate with
phagocytes and propose that the context in which cell death occurs, and the molecules that reflect
this context, shape the inflammatory response.Image courtesy of
Lorenzo Galluzzi
and Oliver Kepp.A Purifying Flame
The acute inflammation induced in a host by invading microorganisms is essential for the induction of
an appropriate response to the infectious threat and for the repair of damaged tissues. Key to these
processes are the cells of the innate immune system—macrophages, dendritic cells, and neutro-
phils—which act as sophisticated sensors of pathogenic stimuli as well as the first line of defense against infection. The
Review by Osamu Takeuchi and Shizuo Akira (page 805) discusses the innate pattern recognition receptors of these cells
that detect pathogens and that, when activated, trigger downstream signaling pathways culminating in the production of
inflammatory mediators. But the immune system must patrol not only the extracellular environment but also the intracellular
milieu. Inflammasomes are key to this latter job, as Kate Schroder and Jurg Tschopp discuss (Review, page 821). Inflamma-
somes are molecular platforms that activate the production of inflammatory cytokines to engage innate immune
cells in the inflammatory response. In line with a role for inflammation in tissue homeostasis, the authors point out that inflam-
masomes not only respond to pathogens but can also act as sensors of cellular stress, such as reactive oxygen species.
The biochemical pathways producing reactive oxygen and nitrogen intermediates, such as those involved in the killing of
pathogens engulfed by innate immune cells, are highly conserved. In our Special Issue SnapShot, Carl Nathan and Aihao
Ding (page 871) provide a visual summary of the sources of reactive oxygen and nitrogen intermediates, their targets in
the cell, and the pathways involved in their breakdown.
Triggering of inflammation sensors activates downstream signaling pathways that culminate in the activation of numerous
genes encoding proteins that mediate and regulate the inflammatory process. Stephen Smale (Review, page 833) highlights
the many ways in which proinflammatory genes can be switched on, reflecting on how this mechanistic diversity allows for
both specificity and flexibility in gene regulation depending on the physiological context. Epigenetic regulation also plays
a role, and the author discusses how the chromatin landscape of proinflammatory genes in effector cells influences their
response to inflammatory stimuli.The Importance of Balance and Restraint
The innate immune response is not only the first line of defense against pathogens and injury but also determines the form of
the adaptive immune response, mediated by T and B cells, that follows. T cells, in turn, are able to both amplify the inflam-
matory response and guide it to ensure efficient clearance of pathogens with minimal tissue damage. Dan Littman and Alex-
ander Rudensky (Review, page 845) discuss the balance that protective immune responses must strike, focusing on Th17
cells, which can elicit strong inflammatory responses, and T regulatory (Treg) cells that suppress inflammation.Cell 140, March 19, 2010 ª2010 Elsevier Inc. 755
Th17 cells and Treg cells aremost abundant inmucosal surfaces such as those of the gut, a locale rich inmicrobiota.Wendy
Garret, Jeffrey Gordon, and Laurie Glimcher remind us that we are hosts to diverse microbial communities and that our rela-
tionship with these residents is complex. Their Review (page 859) examines our symbiotic relationship with the microbial
communities living in our gut, and the crosstalk and equilibrium that exist between our immune system and our microbiota.
Breaches in this delicate balance result in autoimmune disease and chronic inflammatory conditions.Image courtesy of Lorenzo Galluzzi and
Oliver Kepp.Extinguishing the Rings of Fire
Protective inflammation curtails the spread of infection and is, importantly, followed by
resolution and the return of the affected tissues to their normal state. The danger of
perpetuation is ever present, as inflammation causes tissue damage and cell death,
which in turn promotes further inflammation. In their Review (page 871), Carl Nathan
and Aihao Ding discuss the multiple forms of nonresolving inflammation that span
the realm from acute to chronic. Against the backdrop of the mechanisms that would
normally ensure resolution, the authors point to failures in the tuning and timingof these
processes that then contribute to pathology. This Review also advances the concept
that tissue damage may be an intended consequence of inflammation, suggesting
that we may have evolved to recognize signs of cell death as an evolutionary strategy
to amplify and better respond to microbial signals. That inflammation can be triggered
and fed by tissue damage has informed our understanding of inflammation not only in
infection and injury but also in diseases of disrupted homeostasis. GokhanHotamisligil
(Review, page 900) examines such diseases from the point of view of the endoplasmic
reticulum (ER) and discusses howER stress intersects with the inflammatory response
to contribute to metabolic diseases such as obesity and type 2 diabetes.Mechanisms that normally would ensure resolution of inflammation can sometimes add to the problem, as is the case with
allergic inflammation. Richard Locksley (Essay, page 777) discusses this paradox, describing how many aspects of the
allergic response, which eventually result in airway remodeling and airflow limitation, resemble normal wound healing and
are likely to be efforts to resolve chronic mucosal irritation. And inflammation contributes to every step of tumor development
and progression, as Sergei Grivennikov, Florian Greten, andMichael Karin point out (Review, page 883). Even the tissue repair
and healing aspects of inflammation resolution pathways can be harnessed by tumors for their own survival and spread.
Targeting the interplay between cell death and inflammation may be a strategy to ameliorate the pathology of chronic
illnesses. Christopher Glass, Kaoru Saijo, Beate Winner, Maria Marchetto, and Fred Gage (Review, page 918) discuss this
prospect in the context of neurodegenerative diseases. The authors examine the destructive cycle of neuronal cell death
and inflammation driven by microglia and astrocytes in the central nervous system. Strategies to contain inflammatory medi-
ators and effector cells may be potential therapeutic approaches for treating Parkinson’s and Alzheimer’s diseases, amyo-
trophic lateral sclerosis, and multiple sclerosis.
Our growing understanding of the pathways that trigger and regulate inflammation has opened new frontiers in the devel-
opment of anti-inflammatory drugs. In his Review (page 935), Charles Dinarello provides a perspective on anti-inflammatory
agents both old and new, starting with the drugs that have long been in our medicine cabinets and then discussing the devel-
opment of new therapeutics for treating acute and chronic inflammation. The author emphasizes the importance of devising
anti-inflammatory therapies that target the pathological aspect of inflammation, while sparing protective inflammatory
responses. This will indeed be a challenge for the future.
Looking Forward
This is an exciting time for inflammation research. New genetic and genomic technologies have identified mutations underlying
autoimmune and autoinflammatory diseases. This in turn has shed light on the mechanisms that go awry in these diseases,
informing new approaches to treatment. Lauren Zenewicz, Clara Abraham, Richard Flavell, and Judy Cho (Essay, page 791)
note that we are only beginning to integrate our knowledge of inflammatory mechanisms with the wealth of information derived
from genome-wide sequencing efforts and the gene expression profiling of healthy individuals and those with autoimmune
disease.Not only are new technologies available, but alsonew ideas.DanKastner, IvonaAksentijevich, andRaphaelaGoldbach-
Mansky (Essay, page 784) challenge us to update our thinking about inflammation by offering a new definition of autoinflamma-
tory diseases that reflects our understanding of the crucial role of innate immunity in these pathologies. The authors suggest that
we think of autoinflammatory disease as part of a continuum of autoimmune disease, a reflection of the complex interplay
between the innate and adaptive immune responses in inflammation.
Application of systems biology to elucidate the complexity of inflammatory pathways should provide valuable insights, and
the newest imaging technologies will shed light on the complex cellular interactions that underlie the inflammatory process.
We are excited to bring this collection of Reviews and Essays to our readers and hope that they will inform and inspire the
scientists who have taken on the challenge of understanding inflammation.
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